The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we ...